Trial Details
COMPLETEDBasic Information
| Clinical ID | c4567 |
|---|---|
| Identifier | NCT00308581 |
| Trial Title | Certolizumab in Crohn's Disease Patients With Loss of Response or Intolerance to Infliximab |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | BIOLOGICAL: Certolizumab pegol|BIOLOGICAL: Certolizumab pegol|OTHER: Placebo |
Participant Information
| Sponsor | UCB Pharma |
|---|---|
| City | San Francisco |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2006-04 |
|---|---|
| Primary Completion Date | 2008-04 |
| Completion Date | 2008-04 |